Hannah Lewis

Nov 13, 2024 | beliefnet.com | Hannah Lewis

Dave Coulier, beloved for his role as the lovable Joey Gladstone on the iconic sitcom Full House, has been diagnosed with stage 3 non-Hodgkin lymphoma, a type of cancer that has shaken the 65-year-old star’s world. The diagnosis came after Coulier experienced a sudden upper respiratory infection caused by swelling in his lymph nodes. In a matter of days, what began as a common cold turned into a life-altering diagnosis. “It was pretty overwhelming,” Coulier shared with People magazine.

Nov 6, 2024 | ncfieldfamily.org | Hannah Lewis

Photo credit: Nathaniel_YoungLearn a few fun facts about North Carolina Christmas trees. Real Christmas trees take seven to eight years to mature. More than 94% of all Christmas trees grown in the state are Fraser firs. North Carolina is home to more than 850 growers producing Fraser fir Christmas trees on an estimated 40,000 acres.

Nov 4, 2024 | ncfieldfamily.org | Hannah Lewis

Head to High Point, North Carolina, for the High Point Museum showcasing the history of the area, more than 30 miniatures, living history demonstrations, educational programs, events and so much more. The core gallery of the museum focuses on the history of High Point, including the people who lived, worked and worshiped in the town since its establishment.

Nov 2, 2024 | ncfieldfamily.org | Hannah Lewis

Marion, North Carolina, native Julia Nunnally Duncan used her childhood experiences to write her book, All We Have Loved (Finishing Line Press, 2023). The book offers a look inside small-town Southern life through the intimate portrayal of a woman’s life spent in Western North Carolina. The book consists of a collection of essays and short stories from Duncan’s own life or stories passed down from family.

Oct 30, 2024 | investorshangout.com | Hannah Lewis |Lucas Young |Logan G. Wright |Caleb Price

Category: News Total Views: 5 By : Hannah Lewis Updated: 10-30-2024 Understanding Agenus Inc.’s Current Legal LandscapeAgenus Inc. is drawing attention from investors due to legal challenges impacting the company. As a biotechnology firm, it develops immuno-oncology treatments, but recent developments have triggered concern among stakeholders.